BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 10561344)

  • 1. Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects.
    Stuschke M; Eberhardt W; Pöttgen C; Stamatis G; Wilke H; Stüben G; Stöblen F; Wilhelm HH; Menker H; Teschler H; Müller RD; Budach V; Seeber S; Sack H
    J Clin Oncol; 1999 Sep; 17(9):2700-9. PubMed ID: 10561344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial.
    Pöttgen C; Eberhardt W; Grannass A; Korfee S; Stüben G; Teschler H; Stamatis G; Wagner H; Passlick B; Petersen V; Budach V; Wilhelm H; Wanke I; Hirche H; Wilke HJ; Stuschke M
    J Clin Oncol; 2007 Nov; 25(31):4987-92. PubMed ID: 17971598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of prophylactic cranial irradiation timing on brain relapse rates in patients with stage IIIB non-small-cell lung carcinoma treated with two different chemoradiotherapy regimens.
    Topkan E; Parlak C; Kotek A; Yuksel O; Cengiz M; Ozsahin M; Pehlivan B
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1264-71. PubMed ID: 22172902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
    Le Péchoux C; Dunant A; Senan S; Wolfson A; Quoix E; Faivre-Finn C; Ciuleanu T; Arriagada R; Jones R; Wanders R; Lerouge D; Laplanche A;
    Lancet Oncol; 2009 May; 10(5):467-74. PubMed ID: 19386548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Cranial Irradiation for Patients With Locally Advanced Non-Small-Cell Lung Cancer at High Risk for Brain Metastases.
    Park HS; Decker RH; Wilson LD; Yu JB
    Clin Lung Cancer; 2015 Jul; 16(4):292-7. PubMed ID: 25499149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metastases in N2-positive non-small-cell lung cancer: implications for prophylactic cranial irradiation.
    Bansal M; Boyle T; Ehsan A; Mott FE
    Clin Lung Cancer; 2008 Jul; 9(4):227-9. PubMed ID: 18650171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of prophylactic cranial irradiation in regionally advanced non-small cell lung cancer. A Southwest Oncology Group Study.
    Rusch VW; Griffin BR; Livingston RB
    J Thorac Cardiovasc Surg; 1989 Oct; 98(4):535-9. PubMed ID: 2552227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy.
    Li N; Zeng ZF; Wang SY; Ou W; Ye X; Li J; He XH; Zhang BB; Yang H; Sun HB; Fang Q; Wang BX
    Ann Oncol; 2015 Mar; 26(3):504-9. PubMed ID: 25515658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Present role of prophylactic cranial irradiation].
    Le Péchoux C; Al Mohkles H; Dhermain F
    Bull Cancer; 2013 Jan; 100(1):35-43. PubMed ID: 23306141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic cranial irradiation for patients with lung cancer.
    Pugh TJ; Gaspar LE
    Clin Lung Cancer; 2007 May; 8(6):365-8. PubMed ID: 17562236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation.
    Komaki R; Meyers CA; Shin DM; Garden AS; Byrne K; Nickens JA; Cox JD
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):179-82. PubMed ID: 7642416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?
    Carolan H; Sun AY; Bezjak A; Yi QL; Payne D; Kane G; Waldron J; Leighl N; Feld R; Burkes R; Keshavjee S; Shepherd F
    Lung Cancer; 2005 Jul; 49(1):109-15. PubMed ID: 15949596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic cranial irradiation in locally advanced non-small cell lung cancer: outcome of recursive partitioning analysis group 1 patients.
    Yavuz AA; Topkan E; Onal C; Yavuz MN
    J Exp Clin Cancer Res; 2008 Dec; 27(1):80. PubMed ID: 19055787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).
    Eberhardt WE; Pöttgen C; Gauler TC; Friedel G; Veit S; Heinrich V; Welter S; Budach W; Spengler W; Kimmich M; Fischer B; Schmidberger H; De Ruysscher D; Belka C; Cordes S; Hepp R; Lütke-Brintrup D; Lehmann N; Schuler M; Jöckel KH; Stamatis G; Stuschke M
    J Clin Oncol; 2015 Dec; 33(35):4194-201. PubMed ID: 26527789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases.
    Shaw EG; Su JQ; Eagan RT; Jett JR; Maksymiuk AW; Deigert FA
    J Clin Oncol; 1994 Nov; 12(11):2327-32. PubMed ID: 7964948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of prophylactic cranial irradiation for limited-stage small-cell lung cancer in complete remission.
    Cao KJ; Huang HY; Tu MC; Pan GY
    Chin Med J (Engl); 2005 Aug; 118(15):1258-62. PubMed ID: 16117878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic cranial irradiation in limited-stage small-cell lung cancer: a retrospective analysis.
    Alshehadat S; Sahmoun AE
    Clin Adv Hematol Oncol; 2004 Jun; 2(6):397-400. PubMed ID: 16163213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low doses of prophylactic cranial irradiation effective in limited stage small cell carcinoma of the lung.
    Rubenstein JH; Dosoretz DE; Katin MJ; Blitzer PH; Salenius SA; Floody PA; Harwin WN; Teufel TE; Raymond MG; Reeves JA
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):329-37. PubMed ID: 7673020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.